Lab
Adlera Laboratory LLC
Adlera Laboratory LLC was paid $635K by Medicaid between Feb 2019 and Oct 2023, across 46 billing codes. Its largest line is 80050, General health panel — 24% of everything it billed.
33Billing provider infoADLERA LABORATORY LLC
GREAT FALLS, MT 59401
GREAT FALLS, MT 59401
33aNPI1083171748assigned 02/28/2019
33bProvider typeClinical Medical Laboratory
28Total paid$635K
24GClaims56,828
24DCodes billed46
24AFirst – last monthFeb 2019 – Oct 2023
Compared with peers
Next to other Clinical Medical Laboratory providers in Montana
Rank by total paid#6 of 18
Median peer was paid$125K
This provider vs. median5.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 6,531 | $66K | |
| 2020 | 10,642 | $116K | |
| 2021 | 13,199 | $170K | |
| 2022 | 6,041 | $96K | |
| 2023 | 20,415 | $187K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80050 | General health panel | 24% | 3,303 | 2,742 | $152K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 14% | 4,347 | 3,617 | $89K |
| 80061 | Lipid panel | 7.9% | 5,565 | 4,556 | $50K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 6.5% | 432 | 317 | $41K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.9% | 4,838 | 4,009 | $31K |
| 80053 | Comprehensive metabolic panel | 4.6% | 4,822 | 3,845 | $29K |
| 87631 | 4.5% | 241 | 219 | $29K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.4% | 5,450 | 4,400 | $28K |
| 36415 | Collection of venous blood by venipuncture | 4.4% | 10,816 | 8,888 | $28K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.2% | 2,422 | 1,909 | $20K |
| 84481 | 3.0% | 1,587 | 1,326 | $19K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.8% | 791 | 553 | $18K |
34 more codes
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.8% | 794 | $18K |
| 84439 | 2.2% | 2,367 | $14K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 217 | $10K |
| 82607 | 1.1% | 736 | $7K | |
| 82043 | <1% | 1,502 | $6K | |
| 82570 | <1% | 1,596 | $6K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 388 | $5K |
| 87480 | <1% | 399 | $4K | |
| 87510 | <1% | 399 | $4K | |
| 87660 | <1% | 398 | $4K | |
| 82728 | <1% | 442 | $4K | |
| 84466 | <1% | 398 | $3K | |
| 86803 | <1% | 386 | $3K | |
| 84153 | <1% | 227 | $2K | |
| 86780 | <1% | 245 | $2K | |
| 83540 | <1% | 405 | $2K | |
| 82746 | <1% | 131 | $1K | |
| 83735 | <1% | 221 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 164 | $1K |
| 85610 | <1% | 214 | $569.12 | |
| 87522 | Neg quan hep c or qual rna | <1% | 30 | $299.88 |
| 87492 | <1% | 16 | $299.00 | |
| 87592 | <1% | 16 | $299.00 | |
| 87088 | <1% | 52 | $286.79 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 52 | $282.15 |
| 81001 | <1% | 66 | $156.44 | |
| 85652 | <1% | 60 | $122.10 | |
| 84100 | <1% | 16 | $71.50 | |
| 86592 | <1% | 39 | $47.31 | |
| 82248 | <1% | 18 | $27.85 | |
| 81003 | <1% | 12 | $22.16 | |
| 99000 | 0% | 135 | $0.00 | |
| 83550 | 0% | 13 | $0.00 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 60 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBESICH, TRISTA (CEO)